Endoscopic Stricture Management Device Market – Product (Stents, Balloon Dilators, Balloon Inflation Devices, Bougie Dilators), Application (Esophageal, Colonic, Biliary), End User (Hospitals, Ambulatory Surgery Centers) – Global Forecast (2024 – 2032)

Endoscopic Stricture Management Device Market Size

Endoscopic Stricture Management Device Market size was valued at USD 881 million in 2023 and is expected to reach USD 1.4 billion by 2032 growing at a CAGR of 5.8% over the analysis period. The market is driven by several factors, including ongoing technological advances in endoscopic stricture management devices, increasing prevalence of diseases leading to strictures, and increasing awareness towards early diagnosis of strictures. Additionally, increase in minimally invasive surgical procedures using endoscopes is also driving the demand for endoscopic stricture management devices globally.
 

The growing occurrence of conditions that result in strictures, such as gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), colorectal cancer, and biliary diseases is fuelling the need for efficient endoscopic interventions. According to a study published by British Medical Journal in February 2023, total cases of IBD during 1990 – 2019 increased by about 47.45%. Endoscopic stricture management devices offer a less invasive approach to treating strictures that occurs due to such gastric disorders. As a result, with the growing prevalence of gastric disorders such as IBD and GERD, the demand for endoscopic stricture management devices is increasing globally.
 

Endoscopic Stricture Management Device Market Trends

• A growing focus of established market players such as Becton, Dickinson & Company and Cook Medical Inc. towards developing biocompatible and biodegradable materials for stents used in stricture treatments can be observed in the global market. The emergence and acceptance of biodegradable stents present a promising substitute for conventional stents, as they gradually degrade and are absorbed by the body, potentially lowering the chances of enduring complications in the long term.
   

Endoscopic Stricture Management Device Market Analysis

Based on the Product, the global market is classified into stents, balloon dilators, bougie dilators, and other products. The stents segment is further segmented into metal stents, plastic stents, and biodegradable stents. The stents segment has asserted its dominance in the global market by securing a significant share and experiencing growth of 6% between 2024 – 2032.
 

• The dominance is propelled by growing innovations in materials used for manufacturing stents to make them more biocompatible and biodegradable. Moreover, stents offer to maintain long-term luminal patency, and reduce the need for repeat interventions compared to balloon dilation, as they provide sustained mechanical support and help prevent stricture recurrence.
   

Based on the application, the endoscopic stricture management device market is classified into esophageal, colonic, pyloric, biliary, and other applications. The esophageal segment held the largest market share of 36.6% in 2023. This dominance can be attributed to high incidence of strictures caused in esophageal region due to gastric diseases such as GERD; esophageal cancer; eosinophilic esophagitis; IBD, and corrosive injuries.
 

Based on the end user, the endoscopic stricture management device market is classified into hospitals, ambulatory surgery centers, and other end users. The hospital segment is expected to reach USD 827.3 million by 2032.
 

• Hospitals dominate the market due to several key factors. Hospitals possess the necessary infrastructure, such as endoscopy suites, specialized endoscopic tools, and skilled staff, to conduct endoscopic procedures for stricture management with safety and efficiency. Moreover, hospitals have access to reimbursement systems and financial backing to facilitate the procurement of endoscopic devices, supplies, and associated services for stricture management.
   

North America region is projected to maintain its lead in the endoscopic stricture management device market, anticipated to reach USD 543.6 million by 2032.
 

• North America has emerged as the dominant force in the market, owing to several factors including rising incidence of diseases such as GERD, gastrointestinal cancer, and IBD resulting into stricture, and widespread awareness regarding early diagnosis and treatment of stricture.
   
• Moreover, easy access to reimbursement and coverage for endoscopic stricture management also helps to drive the demand for endoscopic stricture management devices, thereby supplementing the market growth.
   

Endoscopic Stricture Management Device Market Share

The market is fragmented with the presence of several established market players and new entrants. Also, the market players are emphasizing towards developing innovative and advanced products that can offer enhanced biocompatibility, improved fit, and better safety to the patients.
 

In this dynamic environment, fierce competition drives companies to distinguish themselves through product innovation, branding, and strategic marketing efforts to cater to the increasing demand for endoscopic stricture management devices.
 

Endoscopic Stricture Management Device Market Companies

Prominent players operating in the endoscopic stricture management device industry are as mentioned below:

• Boston Scientific Corporation
• Olympus Corporation
• CONMED Corporation
• Cook Medical Inc.
• Becton, Dickinson and Company
• Merit Medical Systems
• Medi-Globe GmbH
• PanMed Us
• HOBBS MEDICAL, INC.
• Micro-Tech (Nanjing) Co., Ltd
• Steris plc (Diagmed Healthcare)
• Taewoong Medical Co., Ltd.
   

Endoscopic Stricture Management Device Industry News:

• In October 2022, Medi-Globe GmbH announced to expand in China by inaugurating a new branch in Beijing. As an integral component of its global expansion strategy, the company seeks to enhance support for its trading partners and clinical customers in China. Additionally, it aims to establish a foundation for fostering strategic collaborations with innovative Chinese medical technology firms.
   
• In June 2022, Boston Scientific announced to enter into a definitive agreement with Synergy Innovation Co., Ltd. to acquire majority stakes of M.I.Tech Co., Ltd, Korean manufacturer and distributor of HANAROSTENT technology, a non-vascular, self-expanding metal stents. These non-vascular gastrointestinal stents serve to alleviate occlusions or narrowing in different parts of a patient's anatomy, encompassing the biliary tree, pancreatic duct, esophagus, colon, and duodenum.
   

The endoscopic stricture management device market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Stents
  • Metal stents
  • Plastic stents
  • Biodegradable stents
• Balloon dilators
  • Balloon dilator catheters
  • Balloon inflation devices
• Bougie dilators
• Other products

Market, By Application

• Esophageal
• Colonic
• Pyloric
• Biliary
• Other applications

Market, By End User

• Hospitals
• Ambulatory surgery centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East and Africa